Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
NCT01310413
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
842
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Influenza Vaccines
Interventions
BIOLOGICAL:
Influenza A (H5N1) Virus monovalent vaccine
BIOLOGICAL:
Saline placebo
Sponsor
GlaxoSmithKline